Category: Press Releases
Phase 3 FIGHT-302 Results Presented at ASCO 2026 Evaluate Pemigatinib as a Potential First-Line Treatment Approach for Patients with FGFR2 Fusion- or Rearrangement-Positive Cholangiocarcinoma
Incyte's pemigatinib demonstrated a statistically significant improvement in progression-free survival compared with standard chemotherapy FOR IMMEDIATE RELEASEJune 12, 2026Karen TempletonSenior…
13th Annual Cholangiocarcinoma Foundation Conference Brings Together the Global Community While Honoring CCF’s 20th Anniversary
Bringing together the leading researchers, clinicians, patients, caregivers, and advocates to explore the latest advancements in cholangiocarcinoma Karen TempletonSenior Director…
An Unforgettable Concert Is Coming to Pleasant Grove
Celebrate local talent, support a meaningful cause, and experience an intimate show you won’t find anywhere else in Utah Valley…
Rare Cancer Organization Runs for a Cure at the 2025 Bank of America Chicago Marathon and TCS New York City Marathon
AstraZeneca announced as Gold Level Sponsor in support of rare cancer research SALT LAKE CITY, UTAH — The Cholangiocarcinoma Foundation…
CCF Awards $825,000 in Research Grants
Research grants support early-career, innovative researchers worldwide who are focused on studying cholangiocarcinoma at renowned institutions SALT LAKE CITY, UT,…
Taiho Oncology Europe Announces Availability of Lytgobi® (futibatinib) in Italy for the Treatment of Cholangiocarcinoma
For Trade and Medical Media Only Availability of Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe BAAR, Switzerland, February…
MEDIA ADVISORY
Cholangiocarcinoma Awareness Month: Bringing Light to a Rare and Often Misdiagnosed Cancer WHAT:February is Cholangiocarcinoma Awareness Month, a time dedicated…
Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera®
Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2+ BTC in the U.S. Ziihera received accelerated…
Honoring A Legacy: The Laura Dye Tie Challenge at American Preparatory Academy
WEST VALLEY CITY, UTAH - The American Preparatory Academy-West Valley 1 campus in West Valley City came together to honor…
The Fifth Annual Quack Out Cholangio 5K Run/Walk Raises Funds for Rare Cancer Research
NEWARK, DELAWARE – The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 18th…
Cholangiocarcinoma Foundation Awards $250,000 Innovation Grant to Advance Rare Cancer Research with Funding from Bachrach Family Foundation
The Cholangiocarcinoma Foundation announced the recipients of the 2024 Innovation Grant, generously funded by the Bachrach Family Foundation. The Cholangiocarcinoma…
$550,000 in research grants awarded by the Cholangiocarcinoma Foundation
The Cholangiocarcinoma Foundation, a nonprofit organization funding novel research for bile duct cancer, has awarded the tenth cycle of funding…